Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Sequential Treatment with Rituximab Followed by CHOP Chemotherapy in Adult B-Cell Post-Transplant Lymphoproliferative Disorder (PTLD) - Establishing a New Standard of Care: Final Results From the Prospective International Multicenter PTLD-1 Trial

Ralf Trappe, MD, PhD, Stephan H.K. Oertel, MD, Veronique Leblond, MD, PhD, Peter Mollee, MBBS, MMedSc, Monica Sender, MD, Petra Reinke, MD, PhD, Ruth Neuhaus, MD, Hans Lehmkuhl, MD, PhD, Heinz A. Horst, MD, Gilles Andre Salles, MD, PhD, Franck Morschhauser, Arnaud Jaccard, MD, PhD, Thierry Lamy, MD, PhD, Malte Leithäuser, MD, Ioannis Anagnostopoulos, MD, PhD, Martine Raphael, MD, PhD, Hanno Riess, MD, PhD, Sylvain Choquet, MD

Blood (2011) 118 (21): 878.

https://doi.org/10.1182/blood.V118.21.878.878

Published: 2011

Journal Articles

Primary Central Nervous System (PCNS) Post-Transplant Lymphoproliferative Disease (PTLD): An International Report of 65 Cases in the Modern Era

Andrew M. Evens, DO, MSc, Sylvain Choquet, MD, Aimee Kroll, MS, Sonali M. Smith, MD, Véronique Leblond, MD, PhD, Rupali Roy, MD, Bruce Barton, PhD, Daan Dierickx, MD, David Schiff, MD, Thomas M. Habermann, MD, Ralf Trappe, MD, PhD

Blood (2011) 118 (21): 879.

https://doi.org/10.1182/blood.V118.21.879.879

Published: 2011

Journal Articles

Sequential Treatment with Rituximab and CHOP Chemotherapy in B-Cell PTLD - Moving Forward to a First Standard of Care: Results From a Prospective International Multicenter Trial.

Blood (2009) 114 (22): 100.

https://doi.org/10.1182/blood.V114.22.100.100

Published: 2009

Journal Articles

Presence of Bcr-Abl Positive Cells in Peripheral Blood Leukocytes of Immunosuppressed Solid Organ Transplant (SOT) Recipients

Philipp D. le Coutre, MD, Petra Reinke, Ruth Neuhaus, Ralf Trappe, Frauke Ringel, Philipp Hemmati, Bernd Dörken, Peter Daniel

Blood (2008) 112 (11): 3191.

https://doi.org/10.1182/blood.V112.11.3191.3191

Published: 2008

Journal Articles

Reduction of Immunosuppression and Subsequent Rituximab Monotherapy or CHOP-Based Chemotherapy +/− Rituximab as a Treatment for PTLD Does No Impair the Renal Graft Function: A Matched Pair Control Analysis in 55 Renal Transplant Recipients with PTLD and 1075 Renal Transplant Controls

Ulrike Appel, Carl Hinrichs, Petra Reinke, Nina Babel, Hans H Neumayer, Klemens Budde, Martin Dreyling, Ulrich Dührsen, Volker Kliem, Silke Schüttrumpf, Ingeborg A Hauser, Hans G Mergenthaler, Bernd Dörken, Ioannis Anagnostopoulos, Hanno Riess, Ralf Trappe, On behalf of the German Study Group on PTLD

Blood (2008) 112 (11): 3613.

https://doi.org/10.1182/blood.V112.11.3613.3613

Published: 2008

Journal Articles

Results of the Largest Study on Post-Transplant-Lymphoproliferations (PTLDs) of the Central Nervous System (CNS) in the Rituximab Era: A Surprising Overrepresentation of Kidney Transplantations, Key Importance of Methotrexate (Mtx), Cytarabine (AraC) and Radiotherapy (RX) for Long Term Survival and Low Impact of Rituximab (R)

Sylvain Choquet, Stefan Oertel, Ioannis Anagnostopoulos, Hanno Riess, Madalina Uzunov, V.éronique Leblond, Ralf Trappe

Blood (2008) 112 (11): 3614.

https://doi.org/10.1182/blood.V112.11.3614.3614

Published: 2008

Journal Articles

Sequential Treatment with Rituximab and CHOP Chemotherapy in B-Cell PTLD - A New Standard in Therapy?.

Ralf Trappe, MD, Sylvain Choquet, MD, Stephan Oertel, MD, Veronique LeBlond, MD, Tor Ekman, MD, Monica Sender, MD, Peter Molle, MD, Petra Reinke, MD, Hans Lehmkuhl, MD, Manfred Hummel, MD, Sven Jonas, MD, Ruth Neuhaus, MD, Gilles Salles, MD, Franck Morschhauser, MD, Arnaud Jaccard, MD, Daan Dierickx, MD, Ionannis Anagnostopoulos, MD, Martine Raphael, MD, Hanno Riess, MD

Blood (2007) 110 (11): 390.

https://doi.org/10.1182/blood.V110.11.390.390

Published: 2007

Journal Articles

Sequential Treatment with the Anti-CD 20 Antibody Rituximab and CHOP+GCSF Chemotherapy in Patients with Post-Transplant Lymphoproliferative Disorder (PTLD): First Interim Analysis of a Multicenter Phase II Study.

Ralf Trappe, MD, Stephan Oertel, MD, Sylvain Choquet, MD, Vernoique LeBlond, MD, Matthias Papp-Vary, Hanno Riess, MD

Blood (2005) 106 (11): 932.

https://doi.org/10.1182/blood.V106.11.932.932

Published: 2005

Journal Articles

Fixed-Dose Single Administration of Pegfilgrastim vs Daily Filgrastim in Patients with PTLD Undergoing a Sequential Therapy of Rituximab and CHOP Chemotherapy.

Ralf Trappe, MD, Papp-Vary Matthias, Stephan Oertel, MD, Riess Hanno, MD

Blood (2005) 106 (11): 4724.

https://doi.org/10.1182/blood.V106.11.4724.4724

Published: 2005

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Sequential Treatment with Rituximab Followed by CHOP Chemotherapy in Adult B-Cell Post-Transplant Lymphoproliferative Disorder (PTLD) - Establishing a New Standard of Care: Final Results From the Prospective International Multicenter PTLD-1 Trial

Primary Central Nervous System (PCNS) Post-Transplant Lymphoproliferative Disease (PTLD): An International Report of 65 Cases in the Modern Era

Sequential Treatment with Rituximab and CHOP Chemotherapy in B-Cell PTLD - Moving Forward to a First Standard of Care: Results From a Prospective International Multicenter Trial.

Presence of Bcr-Abl Positive Cells in Peripheral Blood Leukocytes of Immunosuppressed Solid Organ Transplant (SOT) Recipients

Reduction of Immunosuppression and Subsequent Rituximab Monotherapy or CHOP-Based Chemotherapy +/− Rituximab as a Treatment for PTLD Does No Impair the Renal Graft Function: A Matched Pair Control Analysis in 55 Renal Transplant Recipients with PTLD and 1075 Renal Transplant Controls

Sequential Treatment with Rituximab and CHOP Chemotherapy in B-Cell PTLD - A New Standard in Therapy?.

Sequential Treatment with the Anti-CD 20 Antibody Rituximab and CHOP+GCSF Chemotherapy in Patients with Post-Transplant Lymphoproliferative Disorder (PTLD): First Interim Analysis of a Multicenter Phase II Study.

Fixed-Dose Single Administration of Pegfilgrastim vs Daily Filgrastim in Patients with PTLD Undergoing a Sequential Therapy of Rituximab and CHOP Chemotherapy.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only